BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


SEARCH JOBS










 Company News
Interim Data Show Increased Median Overall Survival Of Recurrent Brain Cancer Patients Treated With Tocagen Inc.'s Toca 511 & Toca FC, Compared To Published Benchmarks 11/18/2014 1:25:58 PM
Tocagen Inc. Appoints Faheem Hasnain As Chairman Of The Board Of Directors 11/14/2014 8:25:30 AM
Tocagen Inc. To Present Toca 511 Data At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/11/2014 8:32:15 AM
Tocagen Inc. Expands Clinical Development Team 8/26/2014 9:09:57 AM
Data for Tocagen Inc.'s Toca 511 Presented At The American Society Of Gene And Cell Therapy Annual Meeting 5/22/2014 7:11:23 AM
Tocagen Inc. Names Jamey Skillings, M.D., Chief Medical Officer 3/25/2014 7:07:00 AM
Data Presented At Society For Neuro-Oncology Annual Meeting Demonstrate Tocagen Inc.'s Toca 511 Gene Therapy With Toca FC Was Well Tolerated And Showed Antitumor Activity In Patients With High Grade Glioma 11/26/2013 7:26:57 AM
Voices Against Brain Cancer Awards Grant to Tocagen Inc. to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 6/20/2013 8:57:43 AM
Advancing Neuroscience: IMRIS, MRI Interventions, Inc. (MRIC) and Tocagen Inc. Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors 5/31/2013 9:37:33 AM
MRI Interventions, Inc. (MRIC) Release: Tocagen Inc. to Utilize ClearPoint® Neuro Intervention System for MRI-guided Delivery of Toca 511 in a Study of Patients With Brain Cancer 6/25/2012 10:32:28 AM
12